Modeling of intestinal drug absorption: roles of transporters and metabolic enzymes (for the Gillette Review Series)

KS Pang - Drug metabolism and disposition, 2003 - ASPET
… secretion results in reduced intestinal metabolite formation, as confirmed in a recent
theoretical examination of TM and SFM (unpublished data of KS Pang, E. Tseng, and D. Tam). …

ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport‐mediated PK and DDIs in humans

…, JC Kalvass, S Nagar, KS Pang… - Clinical …, 2013 - Wiley Online Library
This white paper provides a critical analysis of methods for estimating transporter kinetics
and recommendations on proper parameter calculation in various experimental systems. …

Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell …

KS Pang, M Rowland - Journal of pharmacokinetics and biopharmaceutics, 1977 - Springer
Two commonly used models of hepatic drug clearance are examined. The “well-stirred”
model (model I) views the liver as a well-stirred compartment with concentration of drug in the …

Pharmacokinetics of nanoscale quantum dots: in vivo distribution, sequestration, and clearance in the rat

HC Fischer, L Liu, KS Pang… - Advanced Functional …, 2006 - Wiley Online Library
Advances in nanotechnology research on quantum dots (QDs)—water soluble ZnS‐capped,
CdSe fluorescent semiconductor nanocrystals—for in vivo biomedical applications have …

Hepatic clearance of drugs. II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liver …

KS Pang, M Rowland - Journal of pharmacokinetics and biopharmaceutics, 1977 - Springer
Theoretical analysis of two models of hepatic drug clearance revealed that one powerful
discriminator between them is the effect of changes of hepatic blood flow on either the emergent …

The Caco-2 cell monolayer: usefulness and limitations

…, ECY Chow, S Liu, Y Du, KS Pang - Expert opinion on drug …, 2008 - Taylor & Francis
Background: The Caco-2 monolayer has been used extensively for the high-throughput
screening of drug permeability and identification of substrates, inhibitors, and inducers of …

1α, 25-Dihydroxyvitamin D3 reduces cerebral amyloid-β accumulation and improves cognition in mouse models of Alzheimer's disease

…, JT Henderson, PE Fraser, KS Pang - Journal of …, 2014 - Soc Neuroscience
We demonstrate a role of the vitamin D receptor (VDR) in reducing cerebral soluble and
insoluble amyloid-β (Aβ) peptides. Short-term treatment of two human amyloid precursor protein-…

Permeability, transport, and metabolism of solutes in Caco-2 cell monolayers: a theoretical study

H Sun, KS Pang - Drug Metabolism and Disposition, 2008 - ASPET
We explored the properties of a catenary model that includes the basolateral (B), apical (A),
and cellular compartments via simulations under linear and nonlinear conditions to …

Evaluation of exposure change of nonrenally eliminated drugs in patients with chronic kidney disease using physiologically based pharmacokinetic modeling and …

…, Y Sugiyama, KS Pang, KS Reynolds… - The Journal of …, 2012 - Wiley Online Library
… Drs Gil Berglund, Atkinson, Sugiyama, and Pang took sabbaticals from the FDA at
different times between 2008 and 2011. … Sandy Pang PhD … Sandy Pang PhD …

Polymer–lipid hybrid nanoparticles synchronize pharmacokinetics of co-encapsulated doxorubicin–mitomycin C and enable their spatiotemporal co-delivery and local …

…, T Zhang, K Chen, J Li, J Cheng, KS Pang… - … , Biology and Medicine, 2016 - Elsevier
Effective combination chemotherapy requires the delivery of drugs of synergism to tumor
sites while sparing normal tissues. Herein we investigated whether coencapsulation of …